Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
---|
11/24/2011 | US20110288016 Preparation for use of aspartate and vitamin b12 or biotin for regulating ketone bodies |
11/24/2011 | US20110288004 Viral Sequences and Uses Thereof |
11/24/2011 | US20110287092 Compositions comprising decitabine and tetrahydrouridine and uses thereof |
11/24/2011 | US20110286988 FVIII Muteins for Treatment of Von Willebrand Disease |
11/24/2011 | US20110286983 Long lasting drug formulations |
11/24/2011 | US20110286980 Methods for inducing selective apoptosis |
11/24/2011 | US20110286959 Copolymers for suppression of autoimmune diseases, and methods of use |
11/24/2011 | US20110286918 Immunotherapy of autoimmune disorders using antibodies which target b-cells |
11/24/2011 | CA2799390A1 Prodrug of triazolone compound |
11/23/2011 | EP2388265A1 Compositions and methods for the treatment of immune related diseases |
11/23/2011 | EP2388263A1 Imidazo[2,1-b]thiazole derivatives as sirtuin modulators |
11/23/2011 | EP2283011B1 2-phenyl-4-cyclopropyl-pyrimidine derivatives |
11/23/2011 | EP1509541B1 Novel recombinant anticoagulant proteins |
11/23/2011 | EP1467976B1 N-pyrazinyl-phenylsulphonamides and their use in the treatment of chemokine mediated diseases |
11/23/2011 | EP1391451B1 2-iminopyrrolidine derivates |
11/23/2011 | CN1980673B A method for the prevention of thromboembolic disorders |
11/23/2011 | CN102256989A Anionic conjugates of glycosylated bacterial metabolite |
11/23/2011 | CN102256984A Method for producing diamine derivative |
11/23/2011 | CN102256593A Solutions for volume therapy |
11/23/2011 | CN102250738A Health-care wine and production process thereof |
11/23/2011 | CN102250737A Wine with health-care effect |
11/23/2011 | CN102250736A Health-care medicated wine and preparation method thereof |
11/23/2011 | CN102250732A Tussah female moth beautifying wine for women, and production process thereof |
11/23/2011 | CN102250706A Grape wine with nourishing function |
11/23/2011 | CN102250342A PEG/mPEG (Polyethylene Glycol) multi-carboxyl chemical modifying agent connected with citric acid, preparation method and application thereof in modification of toluylene compound |
11/23/2011 | CN102250261A New method for producing iron dextran |
11/23/2011 | CN102250204A RGD sequence peptidyl methyl curcumin compounds, preparation method thereof, and application thereof |
11/23/2011 | CN102250127A Tetrahydro carboline derivative modified with two amino acids and preparation method and application thereof |
11/23/2011 | CN102250099A Non-peptide thrombin inhibitors as well as preparation method and medical application thereof |
11/23/2011 | CN102250097A 6-alkyloxy-2-alkylthio-8-azapurine and synthesis thereof |
11/23/2011 | CN102250094A 2-alkylthio-9-alcoxyalkyl adenine compound and synthesis thereof |
11/23/2011 | CN102250065A Substituted triazine phenyl urea derivatives and application thereof |
11/23/2011 | CN102250064A Glutamic acid derivants |
11/23/2011 | CN102247573A Medicinal injection for treating delirium |
11/23/2011 | CN102247554A Traditional Chinese medicine decoctum for treating dog hemorrhagic gastroenteritis and preparation method thereof |
11/23/2011 | CN102247549A Prescription for treatment of epistaxis |
11/23/2011 | CN102247487A Chinese medicinal preparation and use thereof |
11/23/2011 | CN102247420A Preparation method and application of eclipta extract |
11/23/2011 | CN102247408A Refined pig toenail serving as pangolin scales substitute and preparation method thereof |
11/23/2011 | CN102247406A Chinese medicinal composition for treating cerebral thrombosis |
11/23/2011 | CN102247352A Method for preparing sodium quercetin-7-sulfate and application of sodium quercetin-7-sulfate to preparation of medicaments and health-care products for resisting thrombus |
11/23/2011 | CN102247351A Preparation method of morin-7-sodium sulfovinate and applications thereof in preparing antithrombotic medicaments and health products |
11/23/2011 | CN102247346A Novel anti-coagulation medicinal composition |
11/23/2011 | CN102247333A Clopidogrel hydrogen sulfate tablet and preparation method thereof |
11/23/2011 | CN102247330A Sustained release tablet prepared from raw material of safflower yellow and preparation method thereof |
11/23/2011 | CN102247329A 5,6,7,4'-tetrahydroxyflavone powder injection and preparation method thereof |
11/23/2011 | CN102247328A Salidroside freeze-dried powder injection and preparation method thereof |
11/23/2011 | CN102247317A Vitamin c injection and preparation method thereof |
11/23/2011 | CN102000157B Medicinal liquor with treatment and health-care functions |
11/23/2011 | CN102000025B Novel painless diluent, dilution compatibility method and application of alprostadil fat emulsion preparation |
11/23/2011 | CN101890052B Earthworm crystal powder, preparation process and application thereof |
11/23/2011 | CN101700285B Application of rumex japonicus in preparing medicines |
11/23/2011 | CN101543569B Donkey-hide glue nourishing ointment and preparing method thereof |
11/23/2011 | CN101181412B Chinese medicine prescription orally taken for curing leukocytopenia |
11/22/2011 | US8063036 Benzamides and related inhibitors of factor Xa |
11/22/2011 | US8063020 Resuscitation fluid |
11/22/2011 | US8062638 Prevention and treatment of diseases associated with blood coagulation |
11/22/2011 | US8062635 Bispecific antibody substituting for functional proteins |
11/22/2011 | CA2614323C Use of lactobacillus for increasing the absorption of a metal chosen from fe, zn, ca and ions thereof |
11/22/2011 | CA2489902C Thiazole derivatives as phosphodiesterase iv inhibitors |
11/22/2011 | CA2484395C Bicyclic heterocycles, pharmaceutical compositions containing these compounds, their use and processes for the preparation thereof |
11/22/2011 | CA2473874C A composition for treating neurocerebrovascular disorders |
11/22/2011 | CA2471262C Pyrido(2,1-a)isoquinoline derivatives as dpp-iv inhibitors |
11/17/2011 | WO2011143562A2 Il-1 binding proteins |
11/17/2011 | WO2011143475A1 Lanthanum carbonate hydroxide, lanthanum oxycarbonate and methods of their manufacture and use |
11/17/2011 | WO2011140816A1 Thienopyridine ester derivative containing nitrile, preparation method, use and composition thereof |
11/17/2011 | US20110281951 Compositions and methods for treating amyloidosis |
11/17/2011 | US20110281938 Aptamers to tissue factor pathway inhibitor and their use as bleeding disorder therapeutics |
11/17/2011 | US20110281894 Hemifumarate salt |
11/17/2011 | US20110281884 Fused derivatives as pi3kdelta inhibitors |
11/17/2011 | US20110281880 Methods of administering tetrahydrobiopterin, associated compositions, and methods of measuring |
11/17/2011 | US20110281878 INHIBITORS OF p38 |
11/17/2011 | US20110281850 Intracellular kinase inhibitors |
11/17/2011 | US20110281828 Substituted oxazolidinone derivatives |
11/17/2011 | US20110281825 Inositol pyrophosphates, and methods of use thereof |
11/17/2011 | US20110281820 Glycosaminoglycans derived from k5 polysaccharide having high anticoagulant and antithrombotic activities and process for their preparation |
11/17/2011 | US20110281811 Use Of Leukotriene Inhibitors For Treating Lung Diseases In Prematurely Born Infants |
11/17/2011 | US20110280967 Disintegrable formulations of lanthanum carbonate |
11/17/2011 | US20110280966 Dosing regimens and methods of treatment using carbon monoxide |
11/17/2011 | US20110280956 Lanthanum carbonate hydroxide, lanthanum oxycarbonate and methods of their manufacture and use |
11/17/2011 | US20110280878 Substance specific to human pd-1 |
11/17/2011 | US20110280873 MCP1-Ig FUSION VARIANTS |
11/17/2011 | US20110280857 Advanced functional biocompatible foam used as a hemostatic agent for compressible and non-compressible acute wounds |
11/17/2011 | US20110280830 Albumin Fusion Proteins |
11/17/2011 | US20110280829 Low Molecular Weight Sulphated Polysaccharides as Candidates for Anti-Angiogenic Therapy |
11/17/2011 | US20110280826 Y-shaped polyethylene glycol modified g-csf, the preparation and use thereof |
11/17/2011 | US20110280800 Il-1 binding proteins |
11/16/2011 | EP2386560A1 Crystalline clopidogrel naphthalenesulfonate hydrate, method for preparing same and pharmaceutical composition containing same |
11/16/2011 | EP2386545A1 Heteroaryl ureas containing nitrogen hetero-atoms as P38 kinase inhibitors |
11/16/2011 | EP2385948A1 Fused thiazolo and oxazolo pyrimidinones |
11/16/2011 | EP2385844A2 Complex comprising both heparin binding proteins and heparin-hydroxyalkyl starch conjugates |
11/16/2011 | EP2103630B1 Preparation of low bleeding anticoagulant fusion protein and its use |
11/16/2011 | EP1804780B1 Medium-chain length fatty alcohols as stimulators of hematopoiesis |
11/16/2011 | EP1664089B1 Base-substituted benzylamine analogs for use as coagulation factor xa inhibitors, the production and use thereof |
11/16/2011 | CN1931228B Lysimachia herb total flavone extract and its preparation process |
11/16/2011 | CN1930182B Antithrombotic compound |
11/16/2011 | CN1757637B Method for purifying VE nicotinate raw material |
11/16/2011 | CN102245758A Materials and methds to enhance hematopoietic stem cells engraftment procedures |
11/16/2011 | CN102245181A Heterocyclic benzimidazoles as TRPM8 modulators |
11/16/2011 | CN102242152A Humic acid active component and preparation method, application and pharmaceutical composition thereof |